| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.786 | 27.392 | 39.173 | 34.630 | 31.654 | 22.764 | 19.191 | 14.541 | 12.752 | 9.809 |
| Total Income - EUR | 25.956 | 27.392 | 39.173 | 34.630 | 31.654 | 23.008 | 19.191 | 16.100 | 13.359 | 9.809 |
| Total Expenses - EUR | 17.370 | 20.400 | 23.897 | 26.000 | 20.671 | 13.739 | 14.348 | 17.977 | 16.497 | 12.141 |
| Gross Profit/Loss - EUR | 8.586 | 6.991 | 15.275 | 8.630 | 10.982 | 9.269 | 4.843 | -1.877 | -3.138 | -2.332 |
| Net Profit/Loss - EUR | 7.807 | 6.443 | 13.955 | 8.284 | 10.666 | 9.087 | 4.700 | -1.877 | -3.138 | -2.332 |
| Employees | 4 | 5 | 5 | 3 | 4 | 4 | 5 | 3 | 2 | 1 |
Check the financial reports for the company - Alzette Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.747 | 10.867 | 9.326 | 7.887 | 10.666 | 8.790 | 7.624 | 10.744 | 7.151 | 6.210 |
| Current Assets | 7.517 | 13.597 | 25.255 | 32.274 | 36.829 | 46.403 | 51.568 | 53.016 | 49.876 | 45.549 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 3.156 | 0 | 31.159 | 30.556 | 30.045 | 49.594 | 52.102 | 47.797 | 37.392 |
| Cash | 7.517 | 10.442 | 25.255 | 1.114 | 6.273 | 16.358 | 1.974 | 914 | 2.079 | 8.157 |
| Shareholders Funds | 7.829 | 14.192 | 27.907 | 35.679 | 45.654 | 53.876 | 57.381 | 55.683 | 52.375 | 49.751 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.436 | 10.273 | 6.674 | 4.482 | 1.842 | 1.317 | 1.811 | 8.077 | 4.651 | 2.008 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Alzette Intermed S.r.l.